FDA Struggles To Rein In GLP-1s On The Black Market

FDA Struggles To Rein In GLP-1s On The Black Market Eli Lilly's still-unapproved weight loss drug, retatrutide, has led to several knockoffs being sold on social media. Limited funding is hindering the FDA's ability to crack down on unapproved sellers, Axios reported. https://kffhealthnews.org/morning-breakout/pharma-and-tech-082426/